Viyash Scientific Reports Strong Q4 Performance with Rs 920 Crore Revenue and Rs 52 Crore Profit

Viyash Scientific Limited has announced robust consolidated financial results for the March 2026 quarter, posting revenue from operations of Rs 9.2 billion (Rs 920 crore) and consolidated net profit of Rs 521.1 million (Rs 52.1 crore). The strong quarterly performance reflects healthy demand across the company's scientific instruments and laboratory solutions portfolio, demonstrating solid execution capabilities and market traction in the final quarter of fiscal year 2026

Consolidated Financial Performance Overview

Viyash Scientific Ltd reported consolidated revenue from operations of Rs 920 crore during the January-March 2026 quarter, showcasing the company's scale in India's scientific instruments and laboratory equipment sector. The company posted consolidated net profit of Rs 52.1 crore for the same period, indicating healthy profitability margins despite competitive market dynamics. This performance reflects strong order execution, operational efficiency, and sustained demand from research institutions, pharmaceutical companies, educational establishments, and industrial laboratories that form the company's core customer base.

Sectoral Tailwinds Supporting Growth

The scientific instruments and laboratory equipment industry continues to benefit from increased research and development spending across pharmaceuticals, biotechnology, healthcare diagnostics, and academic institutions. Government initiatives promoting scientific research, quality testing infrastructure, and manufacturing quality control have expanded the addressable market for companies like Viyash Scientific. The company's quarterly results arrive amid growing emphasis on indigenous manufacturing of precision instruments and laboratory consumables.

Profitability and Operational Metrics

With net profit of Rs 52.1 crore on revenue of Rs 920 crore, Viyash Scientific demonstrates a net profit margin of approximately 5.7 percent for the quarter, reflecting the capital-intensive nature of scientific equipment manufacturing and distribution. Investors will watch for management commentary on order book strength, margin trends, working capital efficiency, and growth outlook for the current fiscal year during analyst interactions.

Key Highlights

1. Viyash Scientific reports Q4 FY26 consolidated revenue from operations at Rs 9.2 billion (Rs 920 crore)
2. Consolidated net profit for March quarter stands at Rs 521.1 million (Rs 52.1 crore)
3. Strong quarterly performance reflects healthy demand for scientific instruments and laboratory solutions
4. Results demonstrate solid execution capabilities and market positioning in competitive sector
5. Company benefits from increased R&D spending across pharmaceuticals, biotech, and academic institutions
6. Net profit margin of approximately 5.7 percent indicates operational efficiency in capital-intensive business
7. Performance aligns with government push for indigenous scientific instrumentation and quality infrastructure

Sources: BSE/NSE exchange filings and Viyash Scientific Ltd consolidated quarterly results announcement